Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Leptin promotes weight loss in obese and lean adults

Oct. 28, 1999

More promising results with abarelix in endometriosis

Oct. 28, 1999

Antihypertensive agent unexpectedly found to hold potential as male contraceptive

Oct. 27, 1999

HMR's newest antiresorptive compounds

Oct. 27, 1999

Immtech receives patent coverage for rmCRP in platelet disorders

Oct. 26, 1999

Merck's new GH secretagogues described in recent patent

Oct. 26, 1999

PTPase inhibitors in early development at Novo Nordisk

Oct. 26, 1999

FP receptor agonists claimed by Procter & Gamble for bone disorders, glaucoma

Oct. 26, 1999

AHP's new beta3-adrenoceptor agonists presented in patent literature

Oct. 25, 1999

Three-year subdermal contraceptive implant marketed in the U.K.

Oct. 25, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...